NCT00732823已完成2 期
A Phase II Randomized Study to Evaluate the Safety of the Compression Test Device Using Intermittent Pneumatic Compression Mode in Subjects With Venous Insufficiency and Oedema
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 16
- 试验地点
- 1
- 主要终点
- The nature and frequency of adverse events
研究概览
简要总结
To evaluate the safety of the Compression Device to subjects with venous insufficiency and oedema.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects over 18 years, willing and able to provide written informed consent.
- •Subjects able to wear the Amadeus device and follow the requirements of the clinical investigation plan
- •Subjects who have an ankle to brachial pressure index (ABPI) of ABPI >0.8
- •Subjects with chronic lower limb oedema (i.e. CEAP classification of C3, C4 or C5 1.)
- •Subjects who have Chronic Venous Insufficiency (CVI), which has been present for 6 weeks or longer and who have refluxes >0.5 sec in one or more major venous segments, superficial or deep or both (CEAP classification: C3-C5 1.; Ep,s; As,d; Pr).
排除标准
- •Subjects with a history of skin sensitivity to any of the components of the study product.
- •Subjects who have previously been entered into the study before
- •Subjects who have a history of Deep Vein Thrombosis (DVT) within the last 6 months
- •Subjects who have an active leg ulcer (i.e. CEAP classification of C6 1).
- •Subjects with active cardiac disease or significant history of cardiac disease (including history of myocardial infarction, heart failure, valvular disease, arrhythmia and those with a pacemaker or have previously had a pacemaker).
- •Subjects who have initiated treatment or changed the dose within the past month of pharmaceutical agents that reduce clotting e.g. aspirin (except low-dose aspirin), anti-platelets, anti-coagulants and coumarin.
- •Subjects who are currently taking pharmaceutical agents that can modify the amount of leg oedema (e.g., diuretics, dihydropyridine calcium channel blockers, phlebotonic drugs, or fluctuating doses of systemic steroids) or have taken these agents within the last 10 days.
- •Subjects who are pregnant
- •Subjects who have worn compression therapy in the last 48 hours
- •Subjects who have leg sizes outside the following range:
- •Ankle 17cm - 32cm
- •Calf 27cm - 47cm
- •Below Knee 29cm - 51cm
结局指标
主要结局
The nature and frequency of adverse events
Distal arterial flow
次要结局
- Volume reduction will be measured by recording limb volume at the start and end of each profile for both legs. The test leg will be compared to baseline and the contralateral leg. Comfort during wear will be recorded on completion of each profile
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Compression Device Safety Study on EdemaEdemaNCT00732719ConvaTec Inc.12
已完成
不适用
Open Label Clinical Study to Assess the Clinical Safety of a New Compression Device in Subjects With Peripheral Arterial Vascular DiseasePeripheral Arterial Vascular DiseaseNCT00854516Solventum US LLC15
已完成
不适用
Evaluation of the Safety of Compressive Socks to Treat Venous Insufficiency in Patients With Peripheral Arterial DiseaseVenous InsufficiencyPeripheral Arterial DiseaseNCT02431819Centre Hospitalier Universitaire de Saint Etienne18
已完成
不适用
Venclose RF Ablation System for the Treatment of IPVsChronic Venous InsufficiencyNCT04386785Venclose, Inc.27
Unknown
不适用
External Compression Therapy for Secondary Prevention of Lower-Limb Loss and Cardiovascular MortalityCritical Limb IschemiaNCT02054416Temple University120